PTC Therapeutics
PTCT
PTCT
181 hedge funds and large institutions have $2.48B invested in PTC Therapeutics in 2024 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 52 increasing their positions, 69 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
2.67% less ownership
Funds ownership: 113.8% → 111.13% (-2.7%)
25% less repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 69
72% less call options, than puts
Call options by funds: $5.09M | Put options by funds: $18.4M
Holders
181
Holding in Top 10
4
Calls
$5.09M
Puts
$18.4M
Top Buyers
| 1 | +$41.8M | |
| 2 | +$30.8M | |
| 3 | +$16.5M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$11M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$8.22M |
Top Sellers
| 1 | -$26.6M | |
| 2 | -$21M | |
| 3 | -$15.2M | |
| 4 |
Norges Bank
Oslo,
Norway
|
-$15.1M |
| 5 |
Morgan Stanley
New York
|
-$12.5M |